Preceding Hyperinsulinemia Prevents Demonstration of Insulin Effect on Fat-induced Gastric Inhibitory Polypeptide (GIP)

  1. W Creutzfeldt
  1. Division of Gastroenterology and Metabolism, Department of Medicine, University of Göttingen FRG
  1. Address reprint requests to Prof. Dr. med. Werner Creutzfeldt, Medizinische Universitätsklinik, Robert-Koch-Strasse 40, D-3400 Göttingen, FRG.

Abstract

The effect of insulin on fat-induced gastric inhibitory polypeptide (GIP) release has been studied in seven healthy volunteers during euglycemic blood glucose clamping. In the first protocol, insulin (0.1 U/kg/h) was infused 2 h before ingestion of 100 g fat and continued for 2 h thereafter. In protocol II, saline was infused 2 h before the fat load and the insulin infusion started at the time of fat ingestion. During both insulin infusion studies, glucose levels were clamped at the fasting level by means of the Biostator and plasma levels of insulin, C-peptide, and GIP were estimated by radioimmunoassay. The response of GIP to oral fat was inhibited by 63% if insulin infusion was started at the time of fat ingestion, whereas no inhibition was seen if a 2-h hyperinsulinemic period preceded the fat load. The plasma insulin levels were comparable at the end of each experiment, ranging from 110 to 130 μU/ml. Plasma C-peptide levels decreased during the insulin infusion and increased after fat ingestion. These findings were not the result of inhibition of gastric emptying by insulin because they could be confirmed in four volunteers with intraduodenal infusion of fat. The present data show that insulin does inhibit fat-induced GIP secretion in normal man, but preceding hyperinsulinemic glucose clamping masks this insulin effect, probably by decreasing the sensitivity of the GIP cells to insulin.

  • Received June 1, 1983.
  • Revision received November 3, 1983.
  • Accepted November 3, 1983.
| Table of Contents